Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.

Publication Type:

Journal Article


Cancer causes & control : CCC, Volume 22, Issue 8, p.1121-31 (2011)


2011, Center-Authored Paper, Public Health Sciences Division, September 2011


Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown.